Committee for Medicinal Products for Human Use

ptc therapeutics layoffs, translarna loses eu approval, dmd drug ptc layoffs, translarna dmd drug eu loss, ptc cuts jobs dmd drug setback, translarna withdrawal europe, ptc dmd drug revenue loss,

PTC cuts jobs as Europe withdraws approval for its DMD drug

Anika Sharma

PTC Therapeutics has announced an expansion of its previously planned workforce reductions as European regulatory concerns cast a shadow over ...

Sandoz biosimilar trastuzumab, EirGenix trastuzumab development, CHMP opinion trastuzumab, HER2-positive breast cancer, HER2-positive gastric cancer, EGC002 phase III study, , Sandoz oncology portfolio,

Sandoz gets CHMP nod for biosimilar of Herceptin, a drug for HER2+ breast and gastric cancer

Anika Sharma

Sandoz, a leading global player in generic and biosimilar medications, has received a noteworthy endorsement from the Committee for Medicinal ...

Duchenne muscular dystrophy, PTC Therapeutics, European Medicines Agency, Translarna, Committee for Medicinal Products for Human Use

PTC Therapeutics’ Translarna at risk of losing EU approval after failing to impress FDA for DMD

Anika Sharma

PTC Therapeutics is facing a significant setback as it seeks to maintain approval for its Duchenne muscular dystrophy (DMD) therapy, ...

Omicron variant, Omicron vaccine, Pfizer, BioNTech, CHMP positive opinion, Committee for Medicinal Products for Human Use

Pfizer and BioNTech Get Green Light for Omicron Vaccine in Europe by CHMP

Anika Sharma

Pfizer and BioNTech have unveiled their latest breakthrough in the post COVID era. Brace yourselves for the Omicron XBB.1.5-adapted monovalent ...

Pfizer, Committee for Medicinal Products for Human Use, European Commission, Respiratory syncytial virus, Abrysvo, EC approval, Pfizer Abrysvo,

EC Approves Pfizer’s Abrysvo, Only RSV vaccine in EU for adults and infants

Anika Sharma

Pfizer has just received approval from the European Commission (EC) for its groundbreaking vaccine, Abrysvo. This vaccine, targeting the respiratory ...

AbbVie Receives Favorable CHMP Opinion for Atogepant as Preventive Treatment for Migraine in Adults

AbbVie Receives Favorable CHMP Opinion for Atogepant as Preventive Treatment for Migraine in Adults

SG Tylor

Source – AbbVie AbbVie announced on June 23, 2023, that the Committee for Medicinal Products for Human Use (CHMP) of ...